Short-form Ron is a novel determinant of ovarian cancer initiation and progressionKatherine Moxley(Oklahoma Cancer Specialists and Research Institute), Magdalena Bieniasz(Oklahoma Medical Research Foundation)Genes & CancerJuly 13, 201610.18632/genesandcancer.109Cited by 18SaveCiteExport RISWatch citationsRelated PapersIdentification of a Key Regulator of Mitochondrial Metabolism, the Lrpprc Protein as a Novel Therapeutic Target in Sdha Overexpressing Ovarian Tumors|Preprints.org|2025|1The Identification of a Key Regulator of Mitochondrial Metabolism, the LRPPRC Protein, as a Novel Therapeutic Target in SDHA-Overexpressing Ovarian Tumors|Cancers|2025|1